Experimental cancer drug tested in humans for first time
NCT ID NCT06130722
Summary
This first-in-human study tested the safety of a new cancer drug called FL115 in patients with advanced solid tumors that have stopped responding to standard treatments. The trial enrolled 18 adults to receive increasing doses of FL115 given weekly through an IV, with careful monitoring for side effects. The main goal was to determine the highest safe dose and understand how the drug behaves in the body before testing its effectiveness against cancer in future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED/METASTATIC SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gabriel Cancer Center
Canton, Ohio, 44718, United States
-
HOAG Memorial Hospital Presbyterian
Newport Beach, California, 92663, United States
-
Moores Cancer Center at UCSD Health
San Diego, California, 92037, United States
Conditions
Explore the condition pages connected to this study.